There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Belite Bio, Inc. ADR (BLTE – Research Report), MacroGenics (MGNX – Research Report) and Axsome Therapeutics (AXSM – Research Report) with bullish sentiments.
Belite Bio, Inc. ADR (BLTE)
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Belite Bio, Inc. ADR today and set a price target of $58.00. The company’s shares closed last Monday at $26.84.
According to TipRanks.com, Chen ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Belite Bio, Inc. ADR with a $57.50 average price target.
See today’s best-performing stocks on TipRanks >>
MacroGenics (MGNX)
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on MacroGenics, with a price target of $35.00. The company’s shares closed last Monday at $3.80, close to its 52-week low of $2.13.
According to TipRanks.com, Burns has 0 stars on 0-5 stars ranking scale with an average return of
MacroGenics has an analyst consensus of Strong Buy, with a price target consensus of $12.86, representing a 221.5% upside. In a report issued on August 9, Barclays also maintained a Buy rating on the stock with a $8.00 price target.
Axsome Therapeutics (AXSM)
H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Axsome Therapeutics today and set a price target of $210.00. The company’s shares closed last Monday at $64.46.
According to TipRanks.com, Selvaraju is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Axsome Therapeutics with a $85.70 average price target, representing a 44.0% upside. In a report issued on August 10, Cantor Fitzgerald also maintained a Buy rating on the stock with a $54.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on BLTE:
- Marin Software (NASDAQ:MRIN) Stock Soars on News of Alliance with Snapchat
- H.C. Wainwright Reaffirms Their Buy Rating on Veru (VERU)
- Cocrystal Pharma (COCP) Gets a Buy from H.C. Wainwright
- Palo Alto Networks (PANW): New Buy Recommendation for This Technology Giant
- Enlivex Therapeutics (ENLV) Receives a Buy from H.C. Wainwright
